The global market for Atropine Sulfate for Injection was valued at US$ 350 million in the year 2023 and is projected to reach a revised size of US$ 530 million by 2030, growing at a CAGR of 6.3% during the forecast period.
Atropine Sulfate for Injection is a sterile powder or solution form of the drug that needs to be dissolved and administered by intravenous or intramuscular injection. Its main ingredient is atropine sulfate, which has a wide range of clinical applications.
North American market for Atropine Sulfate for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Atropine Sulfate for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Atropine Sulfate for Injection include Pfizer, American Regent, Hikma Pharmaceuticals, Apotex, Amneal Pharmaceuticals, Accord Healthcare, China Res Double-Crane, Hebei Kaiwei Pharmaceutical, Hebei Tiancheng Pharmaceutical, Tai Yu Chemical & Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Atropine Sulfate for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atropine Sulfate for Injection.
The Atropine Sulfate for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Atropine Sulfate for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Atropine Sulfate for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer
American Regent
Hikma Pharmaceuticals
Apotex
Amneal Pharmaceuticals
Accord Healthcare
China Res Double-Crane
Hebei Kaiwei Pharmaceutical
Hebei Tiancheng Pharmaceutical
Tai Yu Chemical & Pharmaceutical
Tianjin Jinyao Pharmaceutical
Sunflower Pharmaceutical
China Shineway Pharm
CSPC Ouyi Pharmaceutical
Suicheng Pharmaceutical
Chengdu Brilliant Pharmaceutical
Anhui Changjiang Pharmaceutical
Shanghai Harvest Pharmaceutical
Hubei Xinghua Pharmaceutical
Changzhou Pharmaceutical Factory
Segment by Type
0.5 mg/mL
1 mg/mL
5 mg/ml
Others
Segment by Application
Online Sales
Offline Sales
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Atropine Sulfate for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Atropine Sulfate for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Atropine Sulfate for Injection Market Overview
1.1 Product Definition
1.2 Atropine Sulfate for Injection by Type
1.2.1 Global Atropine Sulfate for Injection Market Value Comparison by Type (2024-2030)
1.2.2 0.5 mg/mL
1.2.3 1 mg/mL
1.2.4 5 mg/ml
1.2.5 Others
1.3 Atropine Sulfate for Injection by Application
1.3.1 Global Atropine Sulfate for Injection Market Value by Application (2024-2030)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Atropine Sulfate for Injection Market Size Estimates and Forecasts
1.4.1 Global Atropine Sulfate for Injection Revenue 2019-2030
1.4.2 Global Atropine Sulfate for Injection Sales 2019-2030
1.4.3 Global Atropine Sulfate for Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Atropine Sulfate for Injection Market Competition by Manufacturers
2.1 Global Atropine Sulfate for Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Atropine Sulfate for Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Atropine Sulfate for Injection Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Atropine Sulfate for Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Atropine Sulfate for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Atropine Sulfate for Injection, Product Type & Application
2.7 Global Key Manufacturers of Atropine Sulfate for Injection, Date of Enter into This Industry
2.8 Global Atropine Sulfate for Injection Market Competitive Situation and Trends
2.8.1 Global Atropine Sulfate for Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Atropine Sulfate for Injection Players Market Share by Revenue
2.8.3 Global Atropine Sulfate for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Atropine Sulfate for Injection Market Scenario by Region
3.1 Global Atropine Sulfate for Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Atropine Sulfate for Injection Sales by Region: 2019-2030
3.2.1 Global Atropine Sulfate for Injection Sales by Region: 2019-2024
3.2.2 Global Atropine Sulfate for Injection Sales by Region: 2025-2030
3.3 Global Atropine Sulfate for Injection Revenue by Region: 2019-2030
3.3.1 Global Atropine Sulfate for Injection Revenue by Region: 2019-2024
3.3.2 Global Atropine Sulfate for Injection Revenue by Region: 2025-2030
3.4 North America Atropine Sulfate for Injection Market Facts & Figures by Country
3.4.1 North America Atropine Sulfate for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Atropine Sulfate for Injection Sales by Country (2019-2030)
3.4.3 North America Atropine Sulfate for Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Atropine Sulfate for Injection Market Facts & Figures by Country
3.5.1 Europe Atropine Sulfate for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Atropine Sulfate for Injection Sales by Country (2019-2030)
3.5.3 Europe Atropine Sulfate for Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Atropine Sulfate for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Atropine Sulfate for Injection Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Atropine Sulfate for Injection Sales by Region (2019-2030)
3.6.3 Asia Pacific Atropine Sulfate for Injection Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Atropine Sulfate for Injection Market Facts & Figures by Country
3.7.1 Latin America Atropine Sulfate for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Atropine Sulfate for Injection Sales by Country (2019-2030)
3.7.3 Latin America Atropine Sulfate for Injection Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Atropine Sulfate for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Atropine Sulfate for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Atropine Sulfate for Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Atropine Sulfate for Injection Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Atropine Sulfate for Injection Sales by Type (2019-2030)
4.1.1 Global Atropine Sulfate for Injection Sales by Type (2019-2024)
4.1.2 Global Atropine Sulfate for Injection Sales by Type (2025-2030)
4.1.3 Global Atropine Sulfate for Injection Sales Market Share by Type (2019-2030)
4.2 Global Atropine Sulfate for Injection Revenue by Type (2019-2030)
4.2.1 Global Atropine Sulfate for Injection Revenue by Type (2019-2024)
4.2.2 Global Atropine Sulfate for Injection Revenue by Type (2025-2030)
4.2.3 Global Atropine Sulfate for Injection Revenue Market Share by Type (2019-2030)
4.3 Global Atropine Sulfate for Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Atropine Sulfate for Injection Sales by Application (2019-2030)
5.1.1 Global Atropine Sulfate for Injection Sales by Application (2019-2024)
5.1.2 Global Atropine Sulfate for Injection Sales by Application (2025-2030)
5.1.3 Global Atropine Sulfate for Injection Sales Market Share by Application (2019-2030)
5.2 Global Atropine Sulfate for Injection Revenue by Application (2019-2030)
5.2.1 Global Atropine Sulfate for Injection Revenue by Application (2019-2024)
5.2.2 Global Atropine Sulfate for Injection Revenue by Application (2025-2030)
5.2.3 Global Atropine Sulfate for Injection Revenue Market Share by Application (2019-2030)
5.3 Global Atropine Sulfate for Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Atropine Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Atropine Sulfate for Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 American Regent
6.2.1 American Regent Company Information
6.2.2 American Regent Description and Business Overview
6.2.3 American Regent Atropine Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 American Regent Atropine Sulfate for Injection Product Portfolio
6.2.5 American Regent Recent Developments/Updates
6.3 Hikma Pharmaceuticals
6.3.1 Hikma Pharmaceuticals Company Information
6.3.2 Hikma Pharmaceuticals Description and Business Overview
6.3.3 Hikma Pharmaceuticals Atropine Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Hikma Pharmaceuticals Atropine Sulfate for Injection Product Portfolio
6.3.5 Hikma Pharmaceuticals Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Company Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex Atropine Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Apotex Atropine Sulfate for Injection Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Amneal Pharmaceuticals
6.5.1 Amneal Pharmaceuticals Company Information
6.5.2 Amneal Pharmaceuticals Description and Business Overview
6.5.3 Amneal Pharmaceuticals Atropine Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Amneal Pharmaceuticals Atropine Sulfate for Injection Product Portfolio
6.5.5 Amneal Pharmaceuticals Recent Developments/Updates
6.6 Accord Healthcare
6.6.1 Accord Healthcare Company Information
6.6.2 Accord Healthcare Description and Business Overview
6.6.3 Accord Healthcare Atropine Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Accord Healthcare Atropine Sulfate for Injection Product Portfolio
6.6.5 Accord Healthcare Recent Developments/Updates
6.7 China Res Double-Crane
6.7.1 China Res Double-Crane Company Information
6.7.2 China Res Double-Crane Description and Business Overview
6.7.3 China Res Double-Crane Atropine Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.7.4 China Res Double-Crane Atropine Sulfate for Injection Product Portfolio
6.7.5 China Res Double-Crane Recent Developments/Updates
6.8 Hebei Kaiwei Pharmaceutical
6.8.1 Hebei Kaiwei Pharmaceutical Company Information
6.8.2 Hebei Kaiwei Pharmaceutical Description and Business Overview
6.8.3 Hebei Kaiwei Pharmaceutical Atropine Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hebei Kaiwei Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.8.5 Hebei Kaiwei Pharmaceutical Recent Developments/Updates
6.9 Hebei Tiancheng Pharmaceutical
6.9.1 Hebei Tiancheng Pharmaceutical Company Information
6.9.2 Hebei Tiancheng Pharmaceutical Description and Business Overview
6.9.3 Hebei Tiancheng Pharmaceutical Atropine Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hebei Tiancheng Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.9.5 Hebei Tiancheng Pharmaceutical Recent Developments/Updates
6.10 Tai Yu Chemical & Pharmaceutical
6.10.1 Tai Yu Chemical & Pharmaceutical Company Information
6.10.2 Tai Yu Chemical & Pharmaceutical Description and Business Overview
6.10.3 Tai Yu Chemical & Pharmaceutical Atropine Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Tai Yu Chemical & Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.10.5 Tai Yu Chemical & Pharmaceutical Recent Developments/Updates
6.11 Tianjin Jinyao Pharmaceutical
6.11.1 Tianjin Jinyao Pharmaceutical Company Information
6.11.2 Tianjin Jinyao Pharmaceutical Description and Business Overview
6.11.3 Tianjin Jinyao Pharmaceutical Atropine Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Tianjin Jinyao Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.11.5 Tianjin Jinyao Pharmaceutical Recent Developments/Updates
6.12 Sunflower Pharmaceutical
6.12.1 Sunflower Pharmaceutical Company Information
6.12.2 Sunflower Pharmaceutical Description and Business Overview
6.12.3 Sunflower Pharmaceutical Atropine Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Sunflower Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.12.5 Sunflower Pharmaceutical Recent Developments/Updates
6.13 China Shineway Pharm
6.13.1 China Shineway Pharm Company Information
6.13.2 China Shineway Pharm Description and Business Overview
6.13.3 China Shineway Pharm Atropine Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.13.4 China Shineway Pharm Atropine Sulfate for Injection Product Portfolio
6.13.5 China Shineway Pharm Recent Developments/Updates
6.14 CSPC Ouyi Pharmaceutical
6.14.1 CSPC Ouyi Pharmaceutical Company Information
6.14.2 CSPC Ouyi Pharmaceutical Description and Business Overview
6.14.3 CSPC Ouyi Pharmaceutical Atropine Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.14.4 CSPC Ouyi Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.14.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
6.15 Suicheng Pharmaceutical
6.15.1 Suicheng Pharmaceutical Company Information
6.15.2 Suicheng Pharmaceutical Description and Business Overview
6.15.3 Suicheng Pharmaceutical Atropine Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Suicheng Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.15.5 Suicheng Pharmaceutical Recent Developments/Updates
6.16 Chengdu Brilliant Pharmaceutical
6.16.1 Chengdu Brilliant Pharmaceutical Company Information
6.16.2 Chengdu Brilliant Pharmaceutical Description and Business Overview
6.16.3 Chengdu Brilliant Pharmaceutical Atropine Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Chengdu Brilliant Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.16.5 Chengdu Brilliant Pharmaceutical Recent Developments/Updates
6.17 Anhui Changjiang Pharmaceutical
6.17.1 Anhui Changjiang Pharmaceutical Company Information
6.17.2 Anhui Changjiang Pharmaceutical Description and Business Overview
6.17.3 Anhui Changjiang Pharmaceutical Atropine Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Anhui Changjiang Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.17.5 Anhui Changjiang Pharmaceutical Recent Developments/Updates
6.18 Shanghai Harvest Pharmaceutical
6.18.1 Shanghai Harvest Pharmaceutical Company Information
6.18.2 Shanghai Harvest Pharmaceutical Description and Business Overview
6.18.3 Shanghai Harvest Pharmaceutical Atropine Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Shanghai Harvest Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.18.5 Shanghai Harvest Pharmaceutical Recent Developments/Updates
6.19 Hubei Xinghua Pharmaceutical
6.19.1 Hubei Xinghua Pharmaceutical Company Information
6.19.2 Hubei Xinghua Pharmaceutical Description and Business Overview
6.19.3 Hubei Xinghua Pharmaceutical Atropine Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Hubei Xinghua Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.19.5 Hubei Xinghua Pharmaceutical Recent Developments/Updates
6.20 Changzhou Pharmaceutical Factory
6.20.1 Changzhou Pharmaceutical Factory Company Information
6.20.2 Changzhou Pharmaceutical Factory Description and Business Overview
6.20.3 Changzhou Pharmaceutical Factory Atropine Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Changzhou Pharmaceutical Factory Atropine Sulfate for Injection Product Portfolio
6.20.5 Changzhou Pharmaceutical Factory Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Atropine Sulfate for Injection Industry Chain Analysis
7.2 Atropine Sulfate for Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Atropine Sulfate for Injection Production Mode & Process
7.4 Atropine Sulfate for Injection Sales and Marketing
7.4.1 Atropine Sulfate for Injection Sales Channels
7.4.2 Atropine Sulfate for Injection Distributors
7.5 Atropine Sulfate for Injection Customers
8 Atropine Sulfate for Injection Market Dynamics
8.1 Atropine Sulfate for Injection Industry Trends
8.2 Atropine Sulfate for Injection Market Drivers
8.3 Atropine Sulfate for Injection Market Challenges
8.4 Atropine Sulfate for Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Pfizer
American Regent
Hikma Pharmaceuticals
Apotex
Amneal Pharmaceuticals
Accord Healthcare
China Res Double-Crane
Hebei Kaiwei Pharmaceutical
Hebei Tiancheng Pharmaceutical
Tai Yu Chemical & Pharmaceutical
Tianjin Jinyao Pharmaceutical
Sunflower Pharmaceutical
China Shineway Pharm
CSPC Ouyi Pharmaceutical
Suicheng Pharmaceutical
Chengdu Brilliant Pharmaceutical
Anhui Changjiang Pharmaceutical
Shanghai Harvest Pharmaceutical
Hubei Xinghua Pharmaceutical
Changzhou Pharmaceutical Factory
听
听
*If Applicable.